{
    "SPADE_UN_25846": {
        "Sequence Information": {
            "Peptide Name": "Crabrolin [F1R; L4R; T11R]",
            "Sequence": "RLPRILRKIVRAL",
            "Sequence Length": 13,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Anti-Mammalian Cell",
                "Antibiofilm"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "P01518",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/P01518",
                    "description": "The amino acid sequence of the current peptide coincides with the amino acid sequence of the UniProt entry."
                }
            ],
            "Literature": [
                {
                    "Title": "A Designed Analog of an Antimicrobial Peptide, Crabrolin, Exhibits Enhanced Anti-Proliferative and In Vivo Antimicrobial Activity.",
                    "Pubmed ID": "37833918",
                    "Reference": "Int J Mol Sci. 2023;24:14472",
                    "Author": "Yao A, Ma Y, Sun R, Zou W, Chen X, Zhou M, Ma C, Chen T, Shaw C, Wang L",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/37833918"
                }
            ],
            "Mass": 1604.04,
            "PI": 12.0,
            "Net Charge": 5,
            "Hydrophobicity": 0.22,
            "Frequent Amino Acids": "RLI",
            "Absent Amino Acids": "CDEFGHMNOQSTUWY",
            "Basic Residues": 5,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 7,
            "Polar Residues": 6,
            "Positive Residues": 5,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_25846",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_02350",
                    "Similarity": 1.0,
                    "Sequence": "KHHILRCMGNSGICRASCKKNEQPYLYCRNYQHCCLQSYMRISISGEEENTDWSYEKQWPRLP"
                },
                {
                    "SPADE_ID": "SPADE_UN_02345",
                    "Similarity": 1.0,
                    "Sequence": "DVWWKRLPR"
                },
                {
                    "SPADE_ID": "SPADE_UN_25847",
                    "Similarity": 0.9230769230769231,
                    "Sequence": "RLPRILRKIVRRL"
                }
            ],
            "Hemolytic Activity": "Horse erythrocytes:10% Hemolysis=18.082 µM,Human keratinocytes HaCat:IC50=30.41 µM,Human microvascular endothelial cells HMEC-1:23% Cytotoxicity=100 µM",
            "Target Organism": "Staphylococcus aureus NCTC 10788(MIC=2µM),Staphylococcus aureus NCTC 10788(MBC=2µM),Escherichia coli ATCC 8739(MIC=2µM),Escherichia coli ATCC 8739(MBC=4µM),Staphylococcus aureus NCTC 12493(MIC=4µM),Staphylococcus aureus NCTC 12493(MBC=4µM),Klebsiella pneumoniae ATCC 43816(MIC=8µM),Klebsiella pneumoniae ATCC 43816(MBC=16µM),Enterococcus faecium NTCC 12697(MIC=8µM),Enterococcus faecium NTCC 12697(MBC=16µM),Pseudomonas aeruginosa ATCC 9027(MIC=4µM),Pseudomonas aeruginosa ATCC 9027(MBC=16µM),Human lung adenocarcinoma NCI-H838(IC50=31.51µM),Human prostate adenocarcinoma PC-3(IC50=15.87µM),Human glioblastoma U251-MG(IC50=62.17µM),Human colon adenocarcinoma HCT 116(IC50=30.29µM),Human breast adenocarcinoma MCF-7(IC50=33.85µM)"
        }
    }
}